HUTCHMED (China) Limited
HCM | NASDAQ
$14.09
-$0.39 (-2.69%)
Sep 22, 2026, 12:38 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 5.03 | 65.35 | 30.18 | -6.87 | -28.06 | -35.58 |
PEG Ratio | 0 | -1.03 | -0.24 | -0.10 | -0.72 | -2.85 |
PS Ratio | 4.16 | 3.91 | 3.67 | 5.87 | 15.62 | 19.61 |
PB Ratio | 1.85 | 3.24 | 4.21 | 4.10 | 5.64 | 9.23 |
P/FCF Ratio | -28.96 | -141.38 | 16.49 | -8.20 | -25.17 | -54.74 |
P/OCF Ratio | -35.30 | 4.96K | 14.04 | -9.32 | -27.23 | -72.01 |
OCF/S Ratio | -11.79 | 0.08 | 26.16 | -62.99 | -57.35 | -27.22 |
Debt / Equity Ratio | 0.08 | 0.12 | 0.12 | 0.04 | 0.04 | 0.08 |
Quick Ratio | 4.83 | 2.70 | 2.60 | 2.21 | 3.77 | 3.23 |
Current Ratio | 4.96 | 2.83 | 2.72 | 2.37 | 3.89 | 3.35 |
Asset Turnover | 0.31 | 0.49 | 0.65 | 0.41 | 0.26 | 0.31 |
Interest Coverage | -19.05 | -15.22 | 24.21 | -628.48 | -554.59 | -252.37 |
Return on Equity | 37.01% | 4.96% | 13.80% | -59.12% | -19.72% | -25.97% |
Return on Assets | 26.13% | 2.96% | 7.87% | -35.05% | -14.18% | -17.36% |
Return on Invested Capital | -3.28% | -3.98% | 1.93% | -60.28% | -30.04% | -34.74% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 38.68% | 44.84% | 54.12% | 27.04% | 27.49% | 17.31% |
Net Profit Margin | 83.30% | 5.99% | 12.03% | -84.62% | -54.66% | -55.15% |
Pretax Profit Margin | 95.05% | 7.20% | 12.60% | -84.48% | -43.62% | -48.64% |
Operating Profit Margin | -9.95% | -6.94% | 2.19% | -96.10% | -92.19% | -87.12% |
FCF Margin | -16.15% | -2.77% | 22.27% | -71.59% | -62.05% | -35.81% |
EBITDA Margin | -7.52% | -4.98% | 3.17% | -94.07% | -58.39% | -83.61% |
Add to Watchlist
Select watchlists to add or remove HCM